Pirolazamide

This classification denotes an antidepressant agent with the molecular formula C23H29N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier GQN5BVM24W, chemically known as pyrrolo(1,2-a)pyrazine-2(1h)-butanamide, hexahydro-alpha,alpha-diphenyl- but generally known as pirolazamide, which bears US NIH Compound Identifier 71442. European Medicines Agency schedules Pirolazamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09933MIG. The term PIROLAZAMIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 29, No. 10 1975, List 15). PIROLAZAMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule pirolazamide under HS 29335995 and SITC 51576. As of Q4 2014, PIROLAZAMIDE remains the US FDA Preferred Term for this commodity. Pirolazamide bears US NLM identifiers UMLS ID C0606667 and NCI Concept Code C66432. SMILES: O=C(N)C(CCN1CC2N(CCC2)CC1)(c1ccccc1)c1ccccc1.